Client Services
1800 800 629

  • MIMS Drugs4dent®

    Towards Safer Medication Use: A Tailored Medicines Resource For Dental Practitioners
    +Read More

  • Don’t Rush to Crush+ in eMIMS

    The latest Don’t Rush to Crush release marks the move to a fully digital resource, with rolling updates, with quarterly updates by therapeutic class. To add to your current subscription or to subscribe please call our Client Services Team on 1800 800 629
    +Read More

  • MIMS for Android App

    Now, Android users can find comprehensive, up to date medicines information at the tip of their fingers.
    +Read More

  • eMIMS Classic

    Now eMIMS is available with a choice of platform. eMIMSCloud is internet-based and can be accessed from wherever you are, whereas eMIMS Classic is downloaded to sit on your hard drive. Choose the right eMIMS for you, to suit the way you work.
    +Read More

  • eMIMSCloud

    Now eMIMS is available with a choice of platform. eMIMSCloud is internet-based and can be accessed from wherever you are, whereas eMIMS Classic is downloaded to sit on your hard drive. Choose the right eMIMS for you, to suit the way you work.
    +Read More

  • IMgateway

    Available in eMIMS, this unique, evidence based drug herb and food interaction base developed by a team at the University Of Sydney School Of Pharmacy, provide the health professional with the ability to retrieve information on clinically-significant drug and herb interactions.
    +Read More

  • MIMS - Celebrating 60 momentous years

    In November 2023 MIMS celebrates its 60th birthday. We would like to share some of our milestones.
    +Read More

  • Welcome to MIMS

    Independently edited and abbreviated information on Australian prescription medicines as well as the most commonly used and prescribed over-the-counter and alternative therapies.
    +Read More

  • Markets

    Loved and trusted. The wide spectrum of the Australian healthcare market uses us every day! Servicing the Australian market for just on 60 years.
    +Read More

  • MIMS: A World of Knowledge

    Australia's most trusted and comprehensive drug reference system, used by more than 21,000 healthcare professionals, MIMS offers a wide range of digital products to cover desktop, mobile and integrated data.
    +Read More

  • MIMS: The Gold Standard

    "It has a wealth of information and it makes me confident choosing the right drug for the right person."
    - Survey participant 2010
    +Read More

  • Safer Use of Medicines

    Working closely with healthcare professionals to give peace of mind in medication management, MIMS is a key partner in the safer use of medicines in Australian clinical practice.
    +Read More

  • Support

    MIMS is dedicated to providing responsive service and support with our team of clinical, administrative and technical support officers ready to take your enquiry.
    +Read More
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13

File

Release Date: 01 October 2017
eMIMS Version: updates September 2017 release only
File Name: FullEmimsOct17.exe
Size: 67.6 MB
Description

What's New (Full update)

The October 2017 update includes

  • Additions to the PBS:
    • Adriamycin Concentrate for infusion (Doxorubicin hydrochloride) Pfizer (9d)
      50 mg/25 mL [1]: Section 100 (Chemo, Revised Arrangements) - Public
      50 mg/25 mL [1]: Section 100 (Chemo, Revised Arrangements) - Private
      200 mg/100 mL [1]: Section 100 (Chemo, Revised Arrangements) - Public
      200 mg/100 mL [1]: Section 100 (Chemo, Revised Arrangements) - Private
    • Alprax Tablets (Alprazolam) Aspen Pharma (3b)
      0.5 mg [10]: Authority - PBS/RPBS (NP)
      1 mg [10]: Authority - PBS/RPBS (NP)
    • APOHealth Osteo Relief Paracetamol 665 mg Modified release tablets (Paracetamol) Apotex (4b)
      665 mg [96] x 2: Restricted - Palliative Care (NP)
      665 mg [96] x 2: Restricted - PBS/RPBS (NP)
    • APO-Ibuprofen Tablets (Ibuprofen) Apotex (5a)
      400 mg [30]: PBS/RPBS (MW,NP)
      400 mg [30] x 3: Restricted - PBS/RPBS (NP)
      400 mg [30] x 3: Restricted - Palliative Care (NP)
    • APO-Paroxetine Tablets (Paroxetine) Apotex (3d)
      20 mg [30]: Restricted - PBS/RPBS (NP)
    • Artige Tablets (Methylphenidate hydrochloride) Novartis (3e)
      10 mg [100]: Authority - PBS/RPBS (NP)
    • Ataris Tablets (Leflunomide) Southern Cross Pharma (10c)
      10 mg [30]: Authority (Streamlined) - PBS/RPBS
      20 mg [30]: Authority (Streamlined) - PBS/RPBS
    • Azacitidine Dr. Reddy's Powder for injection (Azacitidine) Dr Reddy's (9b)
      100 mg [1] x 14: Section 100 (Highly Specialised Drugs) - Private - Authority
      100 mg [1] x 14: Section 100 (Highly Specialised Drugs) - Public - Authority
    • Bimatoprost Sandoz Eye drops (Bimatoprost) Sandoz (14c)
      0.3 mg/mL 3 mL [1]: PBS/RPBS (OP)
      0.3 mg/mL 3 mL [1]: PBS/RPBS
    • Maxatan Orally disintegrating tablets (Rizatriptan) Generic Partners (2j)
      10 mg [2] x 2: Restricted - PBS/RPBS (NP)
    • Mirtanza Tablets (Mirtazapine) Apotex (3d)
      15 mg [30]: Restricted - PBS/RPBS (NP)
      30 mg [30]: Restricted - PBS/RPBS (NP)
      45 mg [30]: Restricted - PBS/RPBS (NP)
    • Modafinil Mylan Tablets (Modafinil) Southern Cross Pharma (3e)
      100 mg [60] x 2: Authority - PBS/RPBS
    • Morphine MR Mylan Modified release tablets (Morphine sulfate) Southern Cross Pharma (4a)
      10 mg [28]: Restricted - PBS/RPBS (NP)
      30 mg [28]: Restricted - PBS/RPBS (NP)
      60 mg [28]: Restricted - PBS/RPBS (NP)
      100 mg [28]: Restricted - PBS/RPBS (NP)
    • Novacodone Modified release tablets (Oxycodone hydrochloride) Mundipharma (4a)
      10 mg [28]: Restricted - PBS/RPBS (NP)
      20 mg [28]: Restricted - PBS/RPBS (NP)
      40 mg [28]: Restricted - PBS/RPBS (NP)
      80 mg [28]: Restricted - PBS/RPBS (NP)
    • PKU Anamix First Spoon Powder for oral liquid (multiple actives) Nutricia (19b)
      12.5 g [30] x 8: Restricted - PBS/RPBS (NP)
    • Raloxifene Amneal Tablets (Raloxifene hydrochloride) Amneal (6g)
      60 mg [28]: Authority (Streamlined) - PBS/RPBS (NP)
    • Rexulti Tablets (Brexpiprazole) Lundbeck (3c)
      1 mg [30]: Authority (Streamlined) - PBS/RPBS (NP)
      2 mg [30]: Authority (Streamlined) - PBS/RPBS (NP)
      3 mg [30]: Authority (Streamlined) - PBS/RPBS (NP)
      4 mg [30]: Authority (Streamlined) - PBS/RPBS (NP)
    • Zetin Capsules (Acitretin) Douglas (15b)
      10 mg [100]: Authority (Streamlined) - PBS/RPBS
      25 mg [100]: Authority (Streamlined) - PBS/RPBS
  • Restriction changes:
    • Alprax Tablets (Alprazolam) Aspen Pharma (3b)
      0.5 mg [10]: Authority - PBS/RPBS (NP)
      1 mg [10]: Authority - PBS/RPBS (NP)
    • DBL Cefotaxime Sodium for Injection (Powder for injection) (Cefotaxime) Hospira (8b)
      1 g (solv. req'd) [10]: Restricted - PBS/RPBS (NP)
    • Erivedge Capsules (Vismodegib) Roche (9f)
      150 mg [28]: Authority - PBS/RPBS
    • Eylea Intravitreal injection (Aflibercept) Bayer (14g)
      4 mg/0.1 mL [1]: Authority - PBS/RPBS
    • Humira Prefilled pen (Adalimumab) AbbVie (10c)
      40 mg/0.8 mL [2]: Authority - PBS/RPBS
      40 mg/0.8 mL [6]: Authority - PBS/RPBS
    • Humira Prefilled syringe (Adalimumab) AbbVie (10c)
      40 mg/0.8 mL [2]: Authority - PBS/RPBS
      40 mg/0.8 mL [6]: Authority - PBS/RPBS
    • Kalma Tablets (Alprazolam) Alphapharm (3b)
      0.5 mg [10]: Authority - PBS/RPBS (NP)
      1 mg [10]: Authority - PBS/RPBS (NP)
    • Lucentis Prefilled Syringe (Ranibizumab) Novartis (14g)
      1.65 mg/0.165 mL [1]: Authority - PBS/RPBS
    • Lucentis Vial (Ranibizumab) Novartis (14g)
      2.3 mg/0.23 mL [1]: Authority - PBS/RPBS
    • Novacodone Modified release tablets (Oxycodone hydrochloride) Mundipharma (4a)
      10 mg [28]: Restricted - PBS/RPBS (NP)
      20 mg [28]: Restricted - PBS/RPBS (NP)
      40 mg [28]: Restricted - PBS/RPBS (NP)
      80 mg [28]: Restricted - PBS/RPBS (NP)
    • Oxycodone Sandoz Controlled release tablets (Oxycodone hydrochloride) Sandoz (4a)
      10 mg [28]: Restricted - PBS/RPBS (NP)
      20 mg [28]: Restricted - PBS/RPBS (NP)
      40 mg [28]: Restricted - PBS/RPBS (NP)
      80 mg [28]: Restricted - PBS/RPBS (NP)
    • OxyContin Tablets Reformulated (Modified release tablets) (Oxycodone hydrochloride) Mundipharma (4a)
      10 mg [28]: Restricted - PBS/RPBS (NP)
      20 mg [28]: Restricted - PBS/RPBS (NP)
      40 mg [28]: Restricted - PBS/RPBS (NP)
      80 mg [28]: Restricted - PBS/RPBS (NP)
    • Ozurdex Intravitreal implant (Dexamethasone) Allergan (14g)
      700 mcg [1]: Authority - PBS/RPBS
    • Somavert Powder for injection (Pegvisomant) Pfizer (6c)
      10 mg (+ 30 x 1 mL solv.) [30]: Section 100 (Highly Specialised Drugs) - Private - Authority
      10 mg (+ 30 x 1 mL solv.) [30]: Section 100 (Highly Specialised Drugs) - Public - Authority
      15 mg (+ 30 x 1 mL solv.) [30]: Section 100 (Highly Specialised Drugs) - Private - Authority
      15 mg (+ 30 x 1 mL solv.) [30]: Section 100 (Highly Specialised Drugs) - Public - Authority
      20 mg (+ 1 mL solv.) [1] x 4: Section 100 (Highly Specialised Drugs) - Private - Authority
      20 mg (+ 1 mL solv.) [1] x 4: Section 100 (Highly Specialised Drugs) - Public - Authority
      20 mg (+ 1 mL solv.) [30]: Section 100 (Highly Specialised Drugs) - Private - Authority
      20 mg (+ 1 mL solv.) [30]: Section 100 (Highly Specialised Drugs) - Public - Authority
    • Stelara Solution for intravenous infusion (Ustekinumab) Janssen-Cilag (10c)
      130 mg/26 mL [1] x 4: Section 100 (Highly Specialised Drugs) - Private - Authority
    • Stelara Solution for subcutaneous injection (Ustekinumab) Janssen-Cilag (10c)
      45 mg/0.5 mL [1] x 2: Authority - PBS/RPBS
    • Visudyne Powder for infusion (Verteporfin) Novartis (14g)
      15 mg [1]: Authority - PBS/RPBS
  • Bioequivalence Indicator changes:
    • Brufen Tablets (Ibuprofen) Mylan Health (5a)
      400 mg [30]: PBS/RPBS (MW,NP)
      400 mg [30] x 3: Restricted - PBS/RPBS (NP)
      400 mg [30] x 3: Restricted - Palliative Care (NP)
    • Lumigan Eye Drops (Bimatoprost) Allergan (14c)
      0.3 mg/mL 3 mL [1]: PBS/RPBS (OP)
      0.3 mg/mL 3 mL [1]: PBS/RPBS
    • Ritalin 10 Tablets (Methylphenidate hydrochloride) Novartis (3e)
      10 mg [100]: Authority - PBS/RPBS (NP)
  • the latest MIMS Medicine Information
    • Over 189 updates or additions to the MIMS listings
    New listings include:
    • APOHealth Osteo Relief Paracetamol 665 mg (Paracetamol) Apotex (4b)
    • APO-Ibuprofen (Ibuprofen) Apotex (5a)
    • APO-Paroxetine (Paroxetine) Apotex (3d)
    • Artige (Methylphenidate hydrochloride) Novartis (3e)
    • Ataris (Leflunomide) Southern Cross Pharma (10c)
    • Azacitidine Dr. Reddy's (Azacitidine) Dr Reddy's (9b)
    • Baxter Potassium Chloride and Sodium Chloride Intravenous Infusion (Potassium chloride; sodium chloride) Baxter (19d)
    • Bimatoprost Sandoz (Bimatoprost) Sandoz (14c)
    • Chemists' Own Skin Irritation Cream (Hydrocortisone acetate) Arrow (15e)
    • Chemists' Own Sleep Aid (Doxylamine succinate) Arrow (3a)
    • DermaScar (Polysiloxane) First Pharma Pty Ltd (15a)
    • DermaScar Ultra C (Ascorbic acid; polysiloxane) First Pharma Pty Ltd (15a)
    • DermaScar Ultra Plus C&E (Ascorbic acid; polysiloxane; vitamin E) First Pharma Pty Ltd (15a)
    • Excilor (Acetic acid) First Pharma Pty Ltd (15g)
    • GTA-Amlodipine (Amlodipine) IPCA (2a)
    • Hexaxim (multiple actives) Sanofi-Aventis (10a)
    • Kwells Adult (Hyoscine hydrobromide) Bayer (3h)
    • Kwells Kids (Hyoscine hydrobromide) Bayer (3h)
    • Maxatan (Rizatriptan) Generic Partners (2j)
    • Melatonin MR Apotex (Melatonin) Generic Partners (3a)
    • Mirtanza (Mirtazapine) Apotex (3d)
    • Modafinil Mylan (Modafinil) Southern Cross Pharma (3e)
    • Morphine MR Mylan (Morphine sulfate) Southern Cross Pharma (4a)
    • Nageze Joint Pain (Curcuma longa rhizome dry; terminalia chebula fruit dry) BioRevive (22d)
    • Nageze Osteo Plus (Curcuma longa rhizome dry) BioRevive (22d)
    • Nicotinell Lozenges (Nicotine) Perrigo Australia (20b)
    • Novacodone (Oxycodone hydrochloride) Mundipharma (4a)
    • NovoThirteen (Catridecacog) Novo Nordisk (2l)
    • Phospho-soda (Sodium phosphate) Ferring (1c)
    • PKU Anamix First Spoon (multiple actives) Nutricia (19b)
    • PuraNox Anti-Snoring Spray (multiple actives) First Pharma Pty Ltd (13c)
    • Raloxifene Amneal (Raloxifene hydrochloride) Amneal (6g)
    • Rexulti (Brexpiprazole) Lundbeck (3c)
    • Tecentriq (Atezolizumab) Roche (9f)
    • TriGene Advance (multiple actives) Astley Dolphin (16e)
    • UltraBiotic 60 (multiple actives) FIT-BioCeuticals (1e)
    • UltraBiotic FEMI+ (multiple actives) FIT-BioCeuticals (7d)
    • UltraClean 85 Liquid (multiple actives) FIT-BioCeuticals (21c)
    • Zetin (Acitretin) Douglas (15b)
  • the latest MIMS DrugAlert data
  • the latest CMIs
    • Over 283 updates or additions to the collection

 

  •   PRODUCTS

    We provide a wide range of products that give you the flexibility for the work environment you find yourself in whether you are at your desktop, on the move, need a book! Click here for details on all digital and print products.

  •   DECISION SUPPORT

    Independent of Product Information, these evidence based decision support modules are written by expert clinical staff and sourced from primary international literature covering important information for prescribing, dispensing and administering medicines such as interactions between two or more drugs. Click here for more details.

  •   MARKETS

    MIMS products are highly valued and utilised widely across Australia by healthcare professionals in public and private acute care, primary care, aged care, community services – just to name a few. Click here for full details on all the markets covered.

  •   NEWS

    For all the latest news, publications, and happenings with various products at MIMS...Click here.

    Link your eMIMSCloud to the
    Fred Dispense Plus App Bar today.
    Find out how adding eMIMS will help your work flow by watching this short video.
  • 1